RXO (NYSE:RXO - Get Free Report) had its price objective cut by stock analysts at Wells Fargo & Company from $22.00 to $20.00 in a research note issued to investors on Thursday, March 27th,Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Wells Fargo & Company's price objective suggests a potential upside of 16.35% from the stock's current price.
A number of other equities analysts have also commented on RXO. Truist Financial initiated coverage on RXO in a research note on Thursday, March 13th. They issued a "buy" rating and a $24.00 price objective on the stock. Jefferies Financial Group decreased their price objective on shares of RXO from $33.00 to $30.00 and set a "buy" rating on the stock in a report on Friday, January 10th. The Goldman Sachs Group dropped their target price on shares of RXO from $28.00 to $24.00 and set a "neutral" rating for the company in a research note on Thursday, February 6th. Barclays lowered their price target on shares of RXO from $32.00 to $30.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Finally, Susquehanna decreased their price objective on RXO from $18.00 to $13.00 and set a "negative" rating on the stock in a research report on Wednesday, March 26th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $24.80.
Get Our Latest Report on RXO
RXO Price Performance
Shares of RXO traded down $2.36 during mid-day trading on Thursday, reaching $17.19. The company had a trading volume of 786,334 shares, compared to its average volume of 1,229,333. The company's 50-day moving average is $20.93 and its 200-day moving average is $25.05. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.26 and a quick ratio of 1.33. RXO has a twelve month low of $16.85 and a twelve month high of $32.82. The company has a market capitalization of $2.81 billion, a P/E ratio of -8.11, a P/E/G ratio of 4.55 and a beta of 1.67.
RXO (NYSE:RXO - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, meeting analysts' consensus estimates of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. On average, equities analysts anticipate that RXO will post 0.31 EPS for the current year.
Institutional Investors Weigh In On RXO
A number of hedge funds have recently modified their holdings of RXO. Blue Trust Inc. grew its position in shares of RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock valued at $27,000 after purchasing an additional 510 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in shares of RXO in the third quarter valued at approximately $28,000. Smartleaf Asset Management LLC increased its position in shares of RXO by 228.4% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company's stock worth $30,000 after acquiring an additional 868 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of RXO by 68.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company's stock worth $39,000 after acquiring an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of RXO by 407.0% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock worth $43,000 after acquiring an additional 1,445 shares during the period. Institutional investors and hedge funds own 92.73% of the company's stock.
About RXO
(
Get Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
